Alle Storys
Folgen
Keine Story von Technische Universität München mehr verpassen.

Technische Universität München

Fatal overproduction of antibodies: Mutations in plasma cells play a key role in light chain amyloidosis

TECHNICAL UNIVERSITY OF MUNICH

Corporate Communications Center

phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de

This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35938/

High resolution images: https://mediatum.ub.tum.de/1540362

NEWS RELEASE

Fatal overproduction of antibodies

Mutations in plasma cells play a key role in light chain amyloidosis

Bone marrow plasma cells produce antibodies. These comprise two long and two short protein chains. The pathological proliferation of plasma cells can lead to an overproduction of the short chains. These associate to fibrils and deposit in organs. The result is fatal organ failure. A research team from the Technical University of Munich (TUM) and Heidelberg University has now identified the mutation behind the disease in a patient.

Antibodies are vital for the survival of human beings. They typically consist of two longer and thus heavier amino acid chains and two lighter ones. In rare cases, the plasma cells multiply excessively, flooding the body with light antibody chains.

In people suffering from light chain amyloidosis (AL amyloidosis), these light chains are deposited as extremely fine fibers, so-called amyloid fibrils, in tissue or in organs. The disease is often recognized only after the deposits already compromise the function of organs. In many cases AL amyloidosis is fatal.

"To date, little was known about the exact cause of this amyloidosis," says Johannes Buchner, professor of biotechnology at the Technical University of Munich. “Depending on the organ affected, the symptoms vary considerably. Furthermore, each patient produces different types of antibodies. The disease is thus difficult to diagnose at an early stage.”

A mutation triggers the deadly disease

Using various analytical and database-supported methods, the team of scientists succeeded in identifying eleven mutations caused by the disease in the antibodies of a patient with advanced AL amyloidosis.

Further investigations showed that exactly one mutation was responsible for the destabilization and formation of the disease-causing amyloid fibrils. This mutation causes the unstable light chain to lose its structure after breaking into fragments, which then form the deadly amyloid fibrils.

"Our study shows that mutations that lead to unstable light chains are an important factor in the occurrence of amyloidosis," says Pamina Kazman, who carried out the majority of the measurements. "In the long term, we hope that these and other studies will lead to new, earlier diagnostic methods and possibly even new treatment options."

Publication:

Fatal amyloid formation in a patient’s antibody light chain is caused by a single point mutation

Pamina Kazman, Marie-Theres Vielberg, María Daniela Pulido Cendales, Lioba Hunziger, Benedikt Weber, Ute Hegenbart, Martin Zacharias, Rolf Köhler, Stefan Schönland, Michael Groll, Johannes Buchner

eLife, online: 10.03.2020 – DOI: 10.7554/eLife.52300

https://doi.org/10.7554/eLife.52300

More information:

The research was funded by the German Research Foundation (DFG). The protein structures were determined at the synchrotron radiation sources of the Paul Scherrer Institute in Villigen (Switzerland) and the European synchrotron radiation source in Grenoble (France).

High resolution images:

https://mediatum.ub.tum.de/1540362

Contact:

Prof. Dr. Johannes Buchner

Professorship of Biotechnology

Technical University of Munich

Lichtenbergstr. 4, 85748 Garching, Germany

Tel.: +49 89 289 13340 – E-Mail: johannes.buchner@tum.de

Web: https://www.department.ch.tum.de/en/biotech/

The Technical University of Munich (TUM) is one of Europe’s leading research universities, with around 600 professors, 43,000 students, and 10,000 academic and non-academic staff. Its focus areas are the engineering sciences, natural sciences, life sciences and medicine, combined with economic and social sciences. TUM acts as an entrepreneurial university that promotes talents and creates value for society. In that it profits from having strong partners in science and industry. It is represented worldwide with the TUM Asia campus in Singapore as well as offices in Beijing, Brussels, Cairo, Mumbai, San Francisco, and São Paulo. Nobel Prize winners and inventors such as Rudolf Diesel, Carl von Linde, and Rudolf Mößbauer have done research at TUM. In 2006, 2012 and 2019 it won recognition as a German "Excellence University." In international rankings, TUM regularly places among the best universities in Germany. www.tum.de

Weitere Storys: Technische Universität München
Weitere Storys: Technische Universität München
  • 05.03.2020 – 16:39

    Research towards improved cochlear implants

    TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10808 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35937/ High resolution images: https://mediatum.ub.tum.de/1540122 NEWS RELEASE Research towards improved cochlear implants Computer model shows neuronal activation patterns in the inner ear Cochlear implants ...

  • 04.03.2020 – 11:07

    QS Rankings: TUM among top 50 universities in 11 subjects

    TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35935/ NEWS RELEASE TUM among top 50 universities in 11 subjects New issue of “QS World University Rankings by Subject” The Technical University of Munich (TUM) ranks among the world's best 50 universities ...